These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 25875862
1. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis. González-Ortega I, Alberich S, Echeburúa E, Aizpuru F, Millán E, Vieta E, Matute C, González-Pinto A. PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862 [Abstract] [Full Text] [Related]
2. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study. van der Meer FJ, Velthorst E, Genetic Risk and Outcome of Psychosis (GROUP) Investigators. Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244 [Abstract] [Full Text] [Related]
6. Depressive symptoms in first-episode psychosis: a 10-year follow-up study. Sönmez N, Røssberg JI, Evensen J, Barder HE, Haahr U, Ten Velden Hegelstad W, Joa I, Johannessen JO, Langeveld H, Larsen TK, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T, Friis S. Early Interv Psychiatry; 2016 Jun; 10(3):227-33. PubMed ID: 24956976 [Abstract] [Full Text] [Related]
7. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Degenhardt L, Tennant C, Gilmour S, Schofield D, Nash L, Hall W, McKay D. Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638 [Abstract] [Full Text] [Related]
8. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [Abstract] [Full Text] [Related]
15. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis. González-Ortega I, de Los Mozos V, Echeburúa E, Mezo M, Besga A, Ruiz de Azúa S, González-Pinto A, Gutierrez M, Zorrilla I, González-Pinto A. Psychiatry Res; 2013 Mar 30; 206(1):8-16. PubMed ID: 22985548 [Abstract] [Full Text] [Related]
16. The association between cognitive deficits and depressive symptoms in at-risk mental state: a comparison with first-episode psychosis. Ohmuro N, Matsumoto K, Katsura M, Obara C, Kikuchi T, Hamaie Y, Sakuma A, Iizuka K, Ito F, Matsuoka H. Schizophr Res; 2015 Mar 30; 162(1-3):67-73. PubMed ID: 25618299 [Abstract] [Full Text] [Related]
17. Apathy in first episode psychosis patients: one year follow up. Faerden A, Finset A, Friis S, Agartz I, Barrett EA, Nesvåg R, Andreassen OA, Marder SR, Melle I. Schizophr Res; 2010 Jan 30; 116(1):20-6. PubMed ID: 19948392 [Abstract] [Full Text] [Related]
18. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis. Malcolm CP, Picchioni MM, DiForti M, Sugranyes G, Cooke E, Joseph C, McQueen G, Paparelli A, Stilo S, O'Connor J, Morgan C, Murray RM, Hodgins S. Schizophr Res; 2011 Mar 30; 126(1-3):81-6. PubMed ID: 21186097 [Abstract] [Full Text] [Related]